Impact of scar on water-perfusable tissue index in chronic ischemic heart disease: Evaluation with PET and contrast-enhanced MRI

Molecular Imaging and Biology

Volumn 8, Issue 4, 2006, Pages 245-251

  Knaapen, Paul ^a   Bondarenko, Olga ^a   Beek, Aernout M ^a   Götte, Marco J W ^b   Boellaard, Ronald ^a   van Weerdt, Arno P ^a   Visser, Cees A ^a   van Rossum, Albert C ^a   Lammertsma, Adriaan A ^a   Visser, Frans C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Delayed contrast enhanced MRI; Ischemic heart disease; Perfusable tissue index; Positron emission tomography; Viability

Indexed keywords

CARBON MONOXIDE; OXYGEN 15; TRACER; WATER;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE FIBROSIS; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MALE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REFERENCE VALUE; SCAR; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

AGED; CHRONIC DISEASE; CICATRIX; CORONARY CIRCULATION; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; POSITRON-EMISSION TOMOGRAPHY; TISSUE SURVIVAL; WATER;

EID: 33746868920     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-006-0044-5     Document Type: Article

References (25)

1. Yamamoto Y, de Silva R, Rhodes CG, Araujo LI, Iida H, Rechavia E, Nihoyannopoulos P, Hackett D, Galassi AR, Taylor CJ (1992) A new strategy for the assessment of viable myocardium and regional myocardial blood flow using 15O-water and dynamic positron emission tomography. Circulation 86:167-178
2. de Silva R, Yamamoto Y, Rhodes CG, Iida H, Nihoyannopoulos P, Davies GJ, Lammertsma AA, Jones T, Maseri A (1992) Preoperative prediction of the outcome of coronary revascularization using positron emission tomography. Circulation 86:1738-1742
3. Gerber BL, Melin JA, Bol A, Labar D, Cogneau M, Michel C, Vanoverschelde JL (1998) Nitrogen-13-ammonia and oxygen-15-water estimates of absolute myocardial perfusion in left ventricular ischemic dysfunction. J Nucl Med 39:1655-1662
4. Itoh H, Namura M, Seki H, Asai T, Tsuchiya T, Uenishi H, Fujii H, Fujita S, Tanabe Y, Ito J, Shimizu M, Mabuchi H (2002) Perfusable tissue index obtained by positron emission tomography as a marker of myocardial viability in patients with ischemic ventricular dysfunction. Circ J 66:341-344
5. Knaapen P, Boellaard R, Gotte MJ, van der Weerdt AP, Visser CA, Lammertsma AA, Visser FC (2003) The perfusable tissue index: A marker of myocardial viability. J Nucl Cardiol 10:684-691
6. Iida H, Tamura Y, Kitamura K, Bloomfield PM, Eberl S, Ono Y (2000) Histochemical correlates of (15)O-water-perfusable tissue fraction in experimental canine studies of old myocardial infarction. J Nucl Med 41:1737-1745
7. Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, Klocke FJ, Bonow RO, Kim RJ, Judd RM (2003) Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: An imaging study. Lancet 361:374-379
8. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM (1999) Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100:1992-2002
9. Judd RM, Lugo-Olivieri CH, Arai M, Kondo T, Croisille P, Lima JA, Mohan V, Becker LC, Zerhouni EA (1995) Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 92:1902-1910
10. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM (2000) The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343:1445-1453
11. Wellnhofer E, Olariu A, Klein C, Grafe M, Wahl A, Fleck E, Nagel E (2004) Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation 109:2172-2174
12. Knaapen P, Boellaard R, Gotte MJ, Dijkmans PA, van Campen LM, de Cock CC, Luurtsema G, Visser CA, Lammertsma AA, Visser FC (2004) Perfusable tissue index as a potential marker of fibrosis in patients with idiopathic dilated cardiomyopathy. J Nucl Med 45:1299-1304
13. Iida H, Rhodes CG, de Silva R, Yamamoto Y, Araujo LI, Maseri A, Jones T (1991) Myocardial tissue fraction - correction for partial volume effects and measure of tissue viability. J Nucl Med 32:2169-2175
14. Kuhl HP, Beek AM, van der Weerdt AP, Hofman MB, Visser CA, Lammertsma AA, Heussen N, Visser FC, van Rossum AC (2003) Myocardial viability in chronic ischemic heart disease: Comparison of contrast-enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 41:1341-1348
15. Hermansen F, Rosen SD, Fath-Ordoubadi F, Kooner JS, Clark JC, Camici PG, Lammertsma AA (1998) Measurement of myocardial blood flow with oxygen-15 labelled water: Comparison of different administration protocols. Eur J Nucl Med 25:751-759
16. Bondarenko O, Beek AM, Hofman MB, Kuhl HP, Twisk JW, van Dockum WG, Visser CA, van Rossum AC (2004) Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. J Cardiovasc Magn Reson 7:481-485
17. Herrero P, Staudenherz A, Walsh JF, Gropler RJ, Bergmann SR (1995) Heterogeneity of myocardial perfusion provides the physiological basis of perfusable tissue index. J Nucl Med 36:320-327
18. Iida H, Kanno I, Takahashi A, Miura S, Murakami M, Takahashi K, Ono Y, Shishido F, Inugami A, Tomura N (1988) Measurement of absolute myocardial blood flow with H215O and dynamic positron-emission tomography. Strategy for quantification in relation to the partial-volume effect. Circulation 78:104-115
19. Moon JC, Reed E, Sheppard MN, Elkington AG, Ho SY, Burke M, Petrou M, Pennell DJ (2004) The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 43:2260-2264
20. Alhaddad IA, Kloner RA, Hakim I, Garno JL, Brown EJ (1996) Benefits of late coronary artery reperfusion on infarct expansion progressively diminish over time: Relation to viable islets of myocytes within the scar. Am Heart J 131:451-457
21. Abdel-Aty H, Zagrosek A, Schulz-Menger J, Taylor AJ, Messroghli D, Kumar A, Gross M, Dietz R, Friedrich MG (2004) Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation 109:2411-2416
22. Selvanayagam JB, Kardos A, Francis JM, Wiesmann F, Petersen SE, Taggart DP, Neubauer S (2004) Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation 110:1535-1541
23. Bax JJ, Fath-Ordoubadi F, Boersma E, Wijns W, Camici PG (2002) Accuracy of PET in predicting functional recovery after revascularisation in patients with chronic ischaemic dysfunction: Head-to-head comparison between blood flow, glucose utilisation and water-perfusable tissue fraction. Eur J Nucl Med Mol Imaging 29:721-727
24. Marinho NV, Keogh BE, Costa DC, Lammerstma AA, Ell PJ, Camici PG (1996) Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization. Circulation 93:737-744
25. Camici PG, Rimoldi OE (2003) Myocardial blood flow in patients with hibernating myocardium. Cardiovasc Res 57:302-311